Payment overview · 2025
General Payments
$101.93
6 reported records · 5 companies
Healthcare provider profile · identity verified
Sanjay Ranjit Bharti, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MORGANTOWN, WV · NPI 1376515692
Verified facts
What the public records show
CMS Open Payments records show Sanjay Ranjit Bharti, MD received $101.93 in general payments during 2025 across 6 reported records.
AstraZeneca Pharmaceuticals LP accounted for 31.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Brilinta, Rexulti.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 78 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Lumigan by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 71 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 53 claims for Symbicort by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABILIFY MAINTENA as an associated drug or biological on 2902 records involving 986 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Abilify Maintena by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $31.91 | 31.3% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $22.12 | 21.7% | 1 | 2025 |
| Tonix Medicines, Inc. | Unresolved — no canonical attribution shown | $18.04 | 17.7% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $15.27 | 15.0% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $14.59 | 14.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $101.93 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BRILINTA Normalized: brilinta |
Drug | AstraZeneca Pharmaceuticals LP | $31.91 | 2 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $22.12 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $22.12 | 1 | 2025 |
Source payment records
|
|||||
| TONMYA Normalized: tonmya |
Drug | Tonix Medicines, Inc. | $18.04 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $15.27 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $14.59 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| BRILINTA brilinta |
2025 | Brilinta | 2024 | 30 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 24 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
78 | 21 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
71 | 20 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
53 | 21 |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | ABILIFY MAINTENA open payments reported associated product |
CMS Open Payments — General Payments 2902 supporting records · 986 recipient NPIs · example record 1251759994 |
Abilify Maintena · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1319 | 353 |
| Eliquis | Apixaban | 1220 | 190 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1049 | 228 |
| Gabapentin | Gabapentin | 975 | 201 |
| Furosemide | Furosemide | 931 | 231 |
| Pantoprazole Sodium | Pantoprazole Sodium | 870 | 248 |
| Metoprolol Succinate | Metoprolol Succinate | 747 | 191 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 735 | 125 |
| Amlodipine Besylate | Amlodipine Besylate | 712 | 180 |
| Tamsulosin Hcl | Tamsulosin Hcl | 632 | 159 |
| Lisinopril | Lisinopril | 625 | 168 |
| Metoprolol Tartrate | Metoprolol Tartrate | 554 | 136 |
| Sertraline Hcl | Sertraline Hcl | 482 | 110 |
| Famotidine | Famotidine | 459 | 121 |
| Oxycodone Hcl | Oxycodone Hcl | 451 | 82 |
| Potassium Chloride | Potassium Chloride | 419 | 134 |
| Trazodone Hcl | Trazodone Hcl | 416 | 94 |
| Clopidogrel | Clopidogrel Bisulfate | 415 | 107 |
| Omeprazole | Omeprazole | 400 | 111 |
| Tramadol Hcl | Tramadol Hcl | 383 | 97 |
| Alprazolam | Alprazolam | 350 | 70 |
| Metformin Hcl | Metformin Hcl | 342 | 111 |
| Losartan Potassium | Losartan Potassium | 341 | 103 |
| Duloxetine Hcl | Duloxetine Hcl | 340 | 91 |
| Donepezil Hcl | Donepezil Hcl | 336 | 67 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 334 | 125 |
| Carvedilol | Carvedilol | 329 | 83 |
| Buspirone Hcl | Buspirone Hcl | 302 | 68 |
| Mirtazapine | Mirtazapine | 284 | 66 |
| Ozempic | Semaglutide | 279 | 62 |
| Divalproex Sodium | Divalproex Sodium | 277 | 57 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 258 | 76 |
| Lorazepam | Lorazepam | 256 | 47 |
| Diclofenac Sodium | Diclofenac Sodium | 253 | 71 |
| Quetiapine Fumarate | Quetiapine Fumarate | 250 | 60 |
| Baclofen | Baclofen | 240 | 49 |
| Bumetanide | Bumetanide | 229 | 58 |
| Escitalopram Oxalate | Escitalopram Oxalate | 228 | 61 |
| Levetiracetam | Levetiracetam | 225 | 54 |
| Fluticasone Propionate | Fluticasone Propionate | 223 | 105 |
| Jardiance | Empagliflozin | 223 | 31 |
| Clonazepam | Clonazepam | 222 | 49 |
| Montelukast Sodium | Montelukast Sodium | 217 | 73 |
| Xarelto | Rivaroxaban | 207 | 37 |
| Simvastatin | Simvastatin | 192 | 60 |
| Trulicity | Dulaglutide | 189 | 32 |
| Olanzapine | Olanzapine | 187 | 34 |
| Ropinirole Hcl | Ropinirole Hcl | 181 | 44 |
| Allopurinol | Allopurinol | 180 | 46 |
| Memantine Hcl | Memantine Hcl | 168 | 33 |
| Pregabalin | Pregabalin | 167 | 44 |
| Spironolactone | Spironolactone | 167 | 49 |
| Ondansetron Hcl | Ondansetron Hcl | 163 | 78 |
| Doxycycline Hyclate | Doxycycline Hyclate | 155 | 103 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 155 | 31 |
| Meloxicam | Meloxicam | 151 | 42 |
| Ibuprofen | Ibuprofen | 147 | 40 |
| Citalopram Hbr | Citalopram Hydrobromide | 146 | 33 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 146 | 45 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 145 | 30 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 144 | 46 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 142 | 37 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 141 | 47 |
| Prednisone | Prednisone | 140 | 65 |
| Risperidone | Risperidone | 140 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 139 | 33 |
| Midodrine Hcl | Midodrine Hcl | 133 | 31 |
| Cephalexin | Cephalexin | 132 | 89 |
| Pravastatin Sodium | Pravastatin Sodium | 131 | 41 |
| Lamotrigine | Lamotrigine | 130 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 126 | 42 |
| Aripiprazole | Aripiprazole | 122 | 28 |
| Topiramate | Topiramate | 120 | 20 |
| Finasteride | Finasteride | 118 | 30 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 115 | 81 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 113 | 48 |
| Hydralazine Hcl | Hydralazine Hcl | 111 | 41 |
| Ezetimibe | Ezetimibe | 103 | 34 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 103 | 40 |
| Lactulose | Lactulose | 101 | 29 |
| Ondansetron Odt | Ondansetron | 101 | 44 |
| Amiodarone Hcl | Amiodarone Hcl | 100 | 33 |
| Benztropine Mesylate | Benztropine Mesylate | 99 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 98 | 25 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 92 | 14 |
| Budesonide | Budesonide | 91 | suppressed |
| Bupropion Xl | Bupropion Hcl | 90 | 26 |
| Nystatin | Nystatin | 87 | 50 |
| Paroxetine Hcl | Paroxetine Hcl | 87 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 86 | 25 |
| Latanoprost | Latanoprost | 86 | 26 |
| Mounjaro | Tirzepatide | 84 | 17 |
| Humalog | Insulin Lispro | 83 | 24 |
| Clonidine Hcl | Clonidine Hcl | 82 | 33 |
| Methylprednisolone | Methylprednisolone | 82 | 58 |
| Tizanidine Hcl | Tizanidine Hcl | 82 | 32 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 80 | 23 |
| Novolog Flexpen | Insulin Aspart | 79 | 22 |
| Linzess | Linaclotide | 78 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 78 | 21 |
| Levofloxacin | Levofloxacin | 77 | 48 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 76 | 28 |
| Lidocaine | Lidocaine | 76 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 75 | 20 |
| Sucralfate | Sucralfate | 75 | 21 |
| Nifedipine Er | Nifedipine | 73 | 22 |
| Farxiga | Dapagliflozin Propanediol | 71 | 20 |
| Alendronate Sodium | Alendronate Sodium | 69 | 14 |
| Atenolol | Atenolol | 67 | 28 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 66 | 29 |
| Tradjenta | Linagliptin | 66 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 65 | 47 |
| Incruse Ellipta | Umeclidinium Bromide | 65 | 16 |
| Meclizine Hcl | Meclizine Hcl | 64 | 30 |
| Amitriptyline Hcl | Amitriptyline Hcl | 63 | 23 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 61 | 24 |
| Sodium Chloride | 0.9 % Sodium Chloride | 61 | 28 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 61 | 20 |
| Fentanyl | Fentanyl | 60 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 60 | 19 |
| Azithromycin | Azithromycin | 58 | 48 |
| Glucagon Emergency Kit | Glucagon | 57 | 22 |
| Januvia | Sitagliptin Phosphate | 57 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 55 | 18 |
| Scopolamine | Scopolamine | 55 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 55 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 55 | 31 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 55 | 26 |
| Breo Ellipta | Fluticasone/Vilanterol | 53 | 17 |
| Colchicine | Colchicine | 53 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 53 | 21 |
| Xtampza Er | Oxycodone Myristate | 53 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 52 | 12 |
| Nyamyc | Nystatin | 52 | 23 |
| Myrbetriq | Mirabegron | 51 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 50 | 20 |
| Insulin Lispro | Insulin Lispro | 50 | 22 |
| Nitroglycerin | Nitroglycerin | 49 | 32 |
| Lacosamide | Lacosamide | 47 | 11 |
| Fluconazole | Fluconazole | 46 | 25 |
| Torsemide | Torsemide | 46 | 17 |
| Novolog | Insulin Aspart | 45 | 13 |
| Propranolol Hcl | Propranolol Hcl | 45 | 13 |
| Diazepam | Diazepam | 44 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 44 | suppressed |
| Methocarbamol | Methocarbamol | 44 | 18 |
| Renvela | Sevelamer Carbonate | 44 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 41 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 41 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 41 | 39 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 40 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 40 | 12 |
| Glipizide | Glipizide | 40 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 40 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 40 | suppressed |
| Phenobarbital | Phenobarbital | 40 | suppressed |
| Ertapenem | Ertapenem Sodium | 39 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 39 | suppressed |
| Glimepiride | Glimepiride | 39 | 13 |
| Celecoxib | Celecoxib | 38 | 16 |
| Silver Sulfadiazine | Silver Sulfadiazine | 38 | 16 |
| Lokelma | Sodium Zirconium Cyclosilicate | 37 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 37 | 13 |
| Valsartan | Valsartan | 37 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 36 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 36 | 23 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | 11 |
| Primidone | Primidone | 36 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 36 | 18 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 35 | 15 |
| Breyna | Budesonide/Formoterol Fumarate | 34 | 14 |
| Rivastigmine | Rivastigmine Tartrate | 34 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 34 | 12 |
| Brimonidine Tartrate | Brimonidine Tartrate | 33 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 33 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 33 | suppressed |
| Loperamide | Loperamide Hcl | 33 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 33 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 33 | 13 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 32 | 31 |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 32 | 22 |
| Digoxin | Digoxin | 32 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 32 | 13 |
| Metolazone | Metolazone | 32 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 31 | 19 |
| Meropenem | Meropenem | 31 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 31 | 11 |
| Brilinta | Ticagrelor | 30 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 30 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 30 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 30 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 30 | 25 |
| Temazepam | Temazepam | 30 | suppressed |
| Anastrozole | Anastrozole | 29 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 29 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 29 | suppressed |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 29 | suppressed |
| Ssd | Silver Sulfadiazine | 29 | 12 |
| Vancomycin Hcl | Vancomycin Hcl | 29 | suppressed |
| Buprenorphine | Buprenorphine | 28 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 28 | suppressed |
| Cilostazol | Cilostazol | 28 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 28 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 28 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 27 | 12 |
| Methylphenidate Hcl | Methylphenidate Hcl | 27 | suppressed |
| Multaq | Dronedarone Hcl | 27 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 16 |
| Tiotropium Bromide | Tiotropium Bromide | 27 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 27 | 12 |
| Amoxicillin | Amoxicillin | 26 | 16 |
| Carbamazepine | Carbamazepine | 26 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 26 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 25 | suppressed |
| Entresto | Sacubitril/Valsartan | 25 | 12 |
| Hydromorphone Hcl | Hydromorphone Hcl | 25 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 25 | suppressed |
| Mupirocin | Mupirocin | 25 | 12 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 25 | suppressed |
| Clozapine | Clozapine | 24 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Metronidazole | Metronidazole | 24 | 17 |
| Morphine Sulfate Er | Morphine Sulfate | 24 | suppressed |
| Rexulti | Brexpiprazole | 24 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 24 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 24 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 24 | suppressed |
| Cyclosporine | Cyclosporine | 23 | suppressed |
| Methotrexate | Methotrexate Sodium | 23 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 22 | 16 |
| Irbesartan | Irbesartan | 22 | suppressed |
| Klayesta | Nystatin | 22 | 14 |
| Nystop | Nystatin | 22 | 18 |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 21 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 21 | suppressed |
| Amantadine | Amantadine Hcl | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 20 | suppressed |
| Ranolazine Er | Ranolazine | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Clonidine | Clonidine | 19 | suppressed |
| Haloperidol | Haloperidol | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 19 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 19 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 18 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 18 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 18 | 16 |
| Megestrol Acetate | Megestrol Acetate | 18 | 11 |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 18 | suppressed |
| Oxycontin | Oxycodone Hcl | 18 | suppressed |
| Paliperidone Er | Paliperidone | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 17 | suppressed |
| Admelog Solostar | Insulin Lispro | 16 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 16 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 16 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 16 | 12 |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Prochlorperazine Edisylate | Prochlorperazine Edisylate | 16 | suppressed |
| Rivastigmine | Rivastigmine | 16 | suppressed |
| Acetylcysteine | Acetylcysteine | 15 | 12 |
| Alogliptin | Alogliptin Benzoate | 15 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Erythromycin | Erythromycin Base | 15 | suppressed |
| Linezolid | Linezolid | 15 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Admelog | Insulin Lispro | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | 11 |
| Cefepime Hcl | Cefepime Hcl | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 14 | suppressed |
| Dexamethasone | Dexamethasone | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 14 | suppressed |
| Humira Pen | Adalimumab | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | 11 |
| Levalbuterol Hcl | Levalbuterol Hcl | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Calcium Acetate | Calcium Acetate | 13 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 13 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 13 | suppressed |
| Meprobamate | Meprobamate | 13 | suppressed |
| Solu-Medrol | Methylprednisolone Sod Succ/Pf | 13 | 12 |
| Abilify Maintena | Aripiprazole | 12 | suppressed |
| Bicalutamide | Bicalutamide | 12 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 12 | 12 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Thiothixene | Thiothixene | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 11 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Klor-Con M10 | Potassium Chloride | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Lumigan | Bimatoprost | 11 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $101.93 · 6 records | AstraZeneca Pharmaceuticals LP | AUSTEDO XR, BRILINTA, QULIPTA, REXULTI, TONMYA, UBRELVY | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Brilinta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error